Expectations for September October
One out of seven is not good enough
Maybe this month
Data on Phase 2 Dep Docetaxel and Dep Cabazitaxel human trials
Completion of recruitment and treatment of Viraleze™ human trial
Share price appreciation to reflect the above
Announcement of replacement for CEO
Announcement of retirement of Chairman
Hopefully new submission to FDA for NDA of Vivagel
Announcement of new partners for distribution of Vivagel_b with substantial up front licensing fees
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.27M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 12.5¢ | 12.5¢ | $14.28K | 114.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 151978 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 358000 | 3 |
View Market Depth
| Last trade - 15.01pm 18/09/2025 (20 minute delay) ? |
| SPL (ASX) Chart |